Form D · Other Health Care
Diabetomics, Inc.
Hillsboro, OR · CIK 0001531848
Offering snapshot reported Nov 7, 2014 · SEC filing
- Reported sold
- $2.5M Offering amount: $15M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 27, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 7, 2014 | Initial | $2,500,000 | No comparison | 1 | SEC filing |
| Oct 12, 2011 | Initial | $3,500,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-227932
Source: Form D, filed Nov 7, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chris Dudley | Director |
| Robert Gootee | Director |
| Robert Gregg | Director |
| Dave Gunderson | Director, Executive |
| Rick Miller | Director |
| Srinivasa Rao Nagalla | Director, Executive, Promoter |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2345 Nw Amberbrook Drive Suite 140
Hillsboro, OR, 97006
Hillsboro, OR, 97006